May 13th 2025
Meeting the growing need and demand for fast information to make optimal and timely treatment decisions.
May 9th 2025
Navigating technology and regulatory shifts in pharma revenue management.
The provider hopes that this option will be a solution to the state’s primary care physician shortage.
May 8th 2025
Commissioner Markary announced the plans alongside the results of a generative AI pilot for scientific reviewers.
The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years.
CPhI to Host First India Pharma Week
October 28, 2016.
Astellas to Acquire Germany's Ganymed Pharmaceuticals
October 28, 2016
Seasonal Influenza Vaccines Market Will Hit $4.3 billion by 2025
October 27, 2016
Collaboration Aims to Tackle Africa's "Most Vexing Health Challenges"
October 26, 2016
EMA Gives Open Access to Clinical Data on New Medicines
October 25, 2016
Depression Drugs Sales in the US to Reach $4.6 billion by 2025
October 24, 2016
FDA Awards Grants for Treatments of Rare Diseases
October 19, 2016
Colombia Set for Strong Pharma Market Growth
NICE Announces Fast-Track Approval Plans
October 18, 2016
Astellas to Help Tackle Doping in Sports
October 14, 2016
UN Competition Policy Meeting to Discuss Big Pharma 'Tactics'
Advaxis Approved for $2.5 Million Tax Credit from New Jersey's NOL Program
October 13, 2016
Major Depressive Disorder Market to Reach $5.8 Billion by 2025
October 12, 2016
Medical Tourism Will Help Push UAE Pharma Market to $5.6 Billion by 2020
October 11, 2016
Mylan Reaches Settlement with Department of Justice
Department of Veterans Affairs Awards Genome Sequencing Contract
October 7, 2016
Gastrointestinal Drugs Market to Hit $48.4 Billion by 2022
Lifetime Achievement Award for Cancer Clinician
October 6, 2016
TTIP Could "Lock Europe and US into Higher Drug Prices, Failed Pharma Innovation Model"
October 5, 2016
US to Lose Dominance of Generics Market
Outlook for Biosimilars in 2020
October 3, 2016
Malaysian Pharma Market Set to Reach $3.6 billion by 2020
Counterfeit Drugs Cost Europe More Than €10 Billion a Year
FDA Approves Fourth Biosimilar
September 26, 2016
Tufts CSDD Releases Findings from Diabetes Study
EpiPen Controversy: Mylan CEO Faces Congressional Committee
September 22, 2016
EMA Determines Certain Drugs Safe from Zika Contamination
Australian Pharma Market Set for "Modest Growth" to 2020
Eleven Biotherapeutics Acquires Canada's Viventia Bio
September 21, 2016
Australia Plans to Expedite Drug Approval Process
September 20, 2016